Immunogenicity and safety of Biological E&#39;s CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A prospective double-blind randomized phase III clinical study.

Corbevax (BECOV2D) - Biological E Ltd

Vaxzevria (ChAdOx1-S recombinant) - University of Oxford, Emergent Biosolutions, Jenner Institute, Barinthus Bio, AstraZeneca

Covaxin (BBV152 COVID Vaccine) - Bharat Biotech, Indian Council of Medical Research, Ocugen

http://www.ncbi.nlm.nih.gov/pubmed/41245642

Akshay Binayke; Amit Awasthi; Anil Kumar Pandey; Aymaan Zaheer; Chirag Dhar; Chitta Sitaram Anjaneylu; Kamal Thammireddy; Naveen Chander Reddy; Rammohan Reddy Mogulla; Shiva Narang; Siddalingaiah Ningaiah; SubbaReddy Gunneri; Subhash Thuluva; Vijay Yerroju; Vikram Paradkar

Nov 17, 2025